MedTrace Logo

EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain

NCT05263037 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1093

Last updated 2025-01-29

Study results available
· View outcomes & findings →

Summary

The aim of this randomized controlled trial (RCT) is to assess outcomes for virtual reality therapy (including pain intensity, pain interference, anxiety, depression, physical function, sleep, behavioral skills development, health outcomes and satisfaction) along with healthcare utilization and costs in participants with Chronic Low Back Pain.

Conditions

Interventions

DEVICE

EaseVRx

VR software with interactive content

DEVICE

Sham VR

VR with neutral non-interactive content

Sponsors & Collaborators

  • AppliedVR Inc.

    lead INDUSTRY

Principal Investigators

  • Todd Maddox, Ph.D. · AppliedVR Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2022-10-13
Completion
2026-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05263037 on ClinicalTrials.gov